Compliance and Operations (Toxicology), Vedic Lifesciences Pvt. Ltd., Mumbai, India.
HempRise, 285 Paul Garrett Avenue, Jeffersonville, IN 47130, USA.
ScientificWorldJournal. 2023 Jun 10;2023:3425576. doi: 10.1155/2023/3425576. eCollection 2023.
Broad-spectrum hemp extract is expected to be a promising new intervention for managing stress and anxiety. Research has shown that the cannabinoids found in , such as cannabidiol (CBD), tetrahydrocannabinol (THC), and cannabigerol (CBG), possess anxiolytic properties that can positively impact mood and stress.
In the current study, a broad-spectrum, nondetectable THC hemp extract with other minor cannabinoids (broad-spectrum hemp extract) was administered at 28 mg/kg·bw to evaluate its anxiolytic properties. This was performed using various behavioural models and biomarkers for oxidative stress. In addition, a 300 mg/kg·bw of Ashwagandha root extract was also incorporated to compare its effects on relieving stress and anxiety.
The decreased levels of lipid peroxidation were measured in broad-spectrum hemp extract (36 nmol/ml), Ashwagandha (37 nmol/ml), and induction control (49 nmol/ml) treated groups of animals. The levels of 2-AG decreased in the broad-spectrum hemp extract (1.5 ng/ml), Ashwagandha (1.2 ng/ml), and induction control (2.3 ng/ml) treated groups of animals. The levels of FAAH decreased in broad-spectrum hemp extract (1.6 ng/ml), Ashwagandha (1.7 ng/ml), and induction control (1.9 ng/ml) treated groups of animals. The levels of catalase increased in broad-spectrum hemp extract (35 ng/ml), Ashwagandha (37 ng/ml), and induction control (17 ng/ml) treated groups of animals. Similarly, increased levels of glutathione were found in broad-spectrum hemp extract (30 ng/ml), Ashwagandha (27 ng/ml), and induction control (16 ng/ml) treated groups of animals.
Based on the results of this study, it can be concluded that broad-spectrum hemp extract inhibited the biomarkers for oxidative stress. Also, certain behavioural parameters showed improvements with respect to both the ingredient administered groups.
广谱大麻素提取物有望成为管理压力和焦虑的一种有前途的新干预手段。研究表明,存在于大麻中的大麻素,如大麻二酚(CBD)、四氢大麻酚(THC)和大麻萜酚(CBG),具有抗焦虑特性,可以积极影响情绪和压力。
在目前的研究中,给予 28mg/kg·bw 的广谱、无法检测到 THC 的大麻素提取物(广谱大麻素提取物),以评估其抗焦虑特性。这是通过各种行为模型和氧化应激生物标志物来完成的。此外,还加入了 300mg/kg·bw 的 Ashwagandha 根提取物,以比较其缓解压力和焦虑的效果。
在广谱大麻素提取物(36nmol/ml)、Ashwagandha(37nmol/ml)和诱导对照组(49nmol/ml)处理的动物组中,脂质过氧化水平降低。2-AG 水平在广谱大麻素提取物(1.5ng/ml)、Ashwagandha(1.2ng/ml)和诱导对照组(2.3ng/ml)处理的动物组中降低。FAAH 水平在广谱大麻素提取物(1.6ng/ml)、Ashwagandha(1.7ng/ml)和诱导对照组(1.9ng/ml)处理的动物组中降低。在广谱大麻素提取物(35ng/ml)、Ashwagandha(37ng/ml)和诱导对照组(17ng/ml)处理的动物组中,过氧化氢酶水平增加。同样,在广谱大麻素提取物(30ng/ml)、Ashwagandha(27ng/ml)和诱导对照组(16ng/ml)处理的动物组中,谷胱甘肽水平增加。
根据本研究的结果,可以得出结论,广谱大麻素提取物抑制了氧化应激的生物标志物。此外,某些行为参数在给予的成分组中均有所改善。